Taisei Keitoku

Musashino, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.

Journal: PloS one

Published: June 08, 2025

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.

Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 27, 2023

Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.

Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: October 17, 2023

Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Journal of gastroenterology and hepatology

Published: October 10, 2023

A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.

A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: October 01, 2023

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Journal: Clinical case reports

Published: May 02, 2023

Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.

Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 31, 2023

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.

Journal: BMC gastroenterology

Published: February 18, 2023

Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma.

Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma.

Journal: Cancers

Published: November 22, 2022

Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.

Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.

Journal: Journal of viral hepatitis

Published: October 04, 2022

Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Journal: Cancers

Published: June 22, 2022

Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants.

Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants.

Journal: The American journal of gastroenterology

Published: June 08, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026